Taipei Medical University Hospital
Taipei, Taipei City, 11031, Taiwan
Location status: Recruiting
NCT Number: NCT07830472
The goal of this clinical trial is to learn whether lower-limb rehabilitation robot training combined with nutrition education can improve muscle mass and physical function in adults aged 60 years or older with sarcopenia. The main questions it aims to answer are:
1. Does lower-limb rehabilitation robot training improve muscle mass and body composition? 2. Does the training improve muscle strength, walking ability, balance, and physical function?
Researchers will compare participants who receive lower-limb rehabilitation robot training plus nutrition education with participants who receive usual care, including exercise and nutrition education, to see whether adding robot-assisted training provides additional benefits.
Participants will:
1. Complete assessments before the intervention, around week 5, and after week 8. 2. Receive either 8 weeks of lower-limb rehabilitation robot training using the MRG-P110 plus nutrition education, or usual care including exercise and nutrition education. 3. Complete assessments of body composition, muscle strength, walking ability, balance, and health-related quality of life.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
Taipei, Taipei City, 11031, Taiwan
Location status: Recruiting
Sarcopenia is associated with loss of muscle mass, reduced muscle strength, impaired physical function, and increased risks of falls and disability in older adults. Conventional exercise and nutritional interventions often require longer treatment periods to achieve measurable improvements. Lower-limb rehabilitation robots may provide intensive and repetitive gait training over a shorter period, while nutrition education may support maintenance or improvement of muscle health.
This study uses a two-arm, parallel, quasi-experimental design to evaluate the additional effects of lower-limb rehabilitation robot training when added to nutrition education and usual care in adults with sarcopenia. Participants in both groups will undergo assessments at baseline, mid-intervention, and post-intervention. The study is intended to determine whether this combined approach can provide clinically meaningful improvements in muscle-related and functional outcomes and to assess its feasibility for clinical rehabilitation practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive lower-limb rehabilitation robot training using the MRG-P110 for 8 weeks, three sessions per week, 30 minutes per session, for a total of 24 sessions. Training parameters will be individualized according to participant height and baseline walking speed. Step length will initially be set at 15% of height, and walking speed at 80% of baseline walking speed. Training intensity will be monitored using the Borg Rating of Perceived Exertion scale and maintained at 5-6.
Participants will receive nutrition education as part of the study intervention.
Participants in the control group will receive usual care exercise without additional lower-limb rehabilitation robot training.
Time frame: Baseline, Week 5, and Week 8
Skeletal muscle mass index (SMI) will be measured in kg/m². Lower values indicate lower skeletal muscle mass. According to the criteria used in this study, low muscle mass is defined as SMI ≤7.0 kg/m² in men and ≤5.7 kg/m² in women.
Time frame: Baseline, Week 5, and Week 8
Handgrip strength of the dominant hand will be measured in kilograms (kg). Higher values indicate greater muscle strength. According to the criteria used in this study, low muscle strength is defined as <28 kg in men and <18 kg in women.
Time frame: Baseline, Week 5, and Week 8
Gait speed will be assessed using the 4-meter walk test and reported in meters per second (m/s). Higher values indicate better walking performance. According to the criteria used in this study, a gait speed <1.0 m/s indicates impaired physical performance.
Time frame: Baseline, Week 5, and Week 8
The time required to complete five consecutive sit-to-stand movements will be recorded in seconds. A shorter completion time indicates better lower-limb functional performance.
Time frame: Baseline, Week 5, and Week 8
Walking ability will be assessed using the Functional Ambulation Category (FAC).
Time frame: Baseline, Week 5, and Week 8
Physical performance and balance will be assessed using the Short Physical Performance Battery (SPPB).
Time frame: Baseline, Week 5, and Week 8
Health-related quality of life will be assessed using the EQ-5D questionnaire.
Time frame: Baseline, Week 5, and Week 8
Self-reported lower-extremity function will be assessed using the Lower Extremity Functional Scale (LEFS).
Time frame: Baseline, Week 5, and Week 8
Participants' knowledge and health literacy related to sarcopenia will be assessed using a sarcopenia health literacy questionnaire.
Time frame: Baseline, Week 5, and Week 8
Sarcopenia-specific quality of life will be assessed using the Traditional Chinese short-form sarcopenia quality-of-life questionnaire.
Contact information is provided by the study sponsor or research team.
SHENG-WEN SU
CONTACT
Taipei Medical University Hospital
Other
Research on Lower Limb Rehabilitation Robots for Sarcopenia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531498
Atrophy, Low Muscle Mass
Memphis, Tennessee, United States
View Trial DetailsNCT07817758
Atrophy, Digestive System Diseases
Van, Turkey (Türkiye)
View Trial DetailsNCT06722508
Atrophy, Behavior
Sacramento, California, United States
View Trial DetailsNCT05926219
Aging, Asthenia
Eugene, Oregon, United States
View Trial Details